Literature DB >> 26935136

Strengths and Limitations of Model Systems for the Study of Urinary Tract Infections and Related Pathologies.

Amelia E Barber1, J Paul Norton1, Travis J Wiles1, Matthew A Mulvey2.   

Abstract

Urinary tract infections (UTIs) are some of the most common bacterial infections worldwide and are a source of substantial morbidity among otherwise healthy women. UTIs can be caused by a variety of microbes, but the predominant etiologic agent of these infections is uropathogenic Escherichia coli (UPEC). An especially troubling feature of UPEC-associated UTIs is their high rate of recurrence. This problem is compounded by the drastic increase in the global incidence of antibiotic-resistant UPEC strains over the past 15 years. The need for more-effective treatments for UTIs is driving research aimed at bettering our understanding of the virulence mechanisms and host-pathogen interactions that occur during the course of these infections. Surrogate models of human infection, including cell culture systems and the use of murine, porcine, avian, teleost (zebrafish), and nematode hosts, are being employed to define host and bacterial factors that modulate the pathogenesis of UTIs. These model systems are revealing how UPEC strains can avoid or overcome host defenses and acquire scarce nutrients while also providing insight into the virulence mechanisms used by UPEC within compromised individuals, such as catheterized patients. Here, we summarize our current understanding of UTI pathogenesis while also giving an overview of the model systems used to study the initiation, persistence, and recurrence of UTIs and life-threatening sequelae like urosepsis. Although we focus on UPEC, the experimental systems described here can also provide valuable insight into the disease processes associated with other bacterial pathogens both within the urinary tract and elsewhere within the host.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26935136      PMCID: PMC4867371          DOI: 10.1128/MMBR.00067-15

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  252 in total

1.  Pathogenic Escherichia coli found in sewage treatment plants and environmental waters.

Authors:  E M Anastasi; B Matthews; H M Stratton; M Katouli
Journal:  Appl Environ Microbiol       Date:  2012-06-01       Impact factor: 4.792

2.  Inactivation of host Akt/protein kinase B signaling by bacterial pore-forming toxins.

Authors:  Travis J Wiles; Bijaya K Dhakal; Danelle S Eto; Matthew A Mulvey
Journal:  Mol Biol Cell       Date:  2008-01-30       Impact factor: 4.138

3.  Transcriptional analysis of the MrpJ network: modulation of diverse virulence-associated genes and direct regulation of mrp fimbrial and flhDC flagellar operons in Proteus mirabilis.

Authors:  Nadine J Bode; Irina Debnath; Lisa Kuan; Anjelique Schulfer; Maureen Ty; Melanie M Pearson
Journal:  Infect Immun       Date:  2015-04-06       Impact factor: 3.441

4.  Severity of Escherichia coli bacteraemia is independent of the intrinsic virulence of the strains assessed in a mouse model.

Authors:  L Landraud; F Jauréguy; E Frapy; G Guigon; S Gouriou; E Carbonnelle; O Clermont; E Denamur; B Picard; E Lemichez; S Brisse; X Nassif
Journal:  Clin Microbiol Infect       Date:  2012-01-23       Impact factor: 8.067

5.  CD46 (membrane cofactor protein) acts as a human epithelial cell receptor for internalization of opsonized uropathogenic Escherichia coli.

Authors:  Ke Li; Maria Jose Feito; Steven H Sacks; Neil S Sheerin
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

6.  Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases.

Authors:  J-P Lavigne; A-B Blanc-Potard; G Bourg; J Moreau; C Chanal; N Bouziges; D O'callaghan; A Sotto
Journal:  Clin Microbiol Infect       Date:  2006-12       Impact factor: 8.067

7.  Renal damage due to urinary tract infection.

Authors:  A W Asscher
Journal:  Contrib Nephrol       Date:  1979       Impact factor: 1.580

8.  Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation.

Authors:  Lynette Cegelski; Jerome S Pinkner; Neal D Hammer; Corinne K Cusumano; Chia S Hung; Erik Chorell; Veronica Aberg; Jennifer N Walker; Patrick C Seed; Fredrik Almqvist; Matthew R Chapman; Scott J Hultgren
Journal:  Nat Chem Biol       Date:  2009-10-25       Impact factor: 15.040

9.  Dynamin2- and endothelial nitric oxide synthase-regulated invasion of bladder epithelial cells by uropathogenic Escherichia coli.

Authors:  Zhimin Wang; Ceba Humphrey; Nicole Frilot; Gaofeng Wang; Zhongzhen Nie; Nader H Moniri; Yehia Daaka
Journal:  J Cell Biol       Date:  2011-01-10       Impact factor: 10.539

10.  Freeze-fracture replica immunolabelling reveals urothelial plaques in cultured urothelial cells.

Authors:  Mateja Erdani Kreft; Horst Robenek
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

View more
  18 in total

Review 1.  Invasion of Host Cells and Tissues by Uropathogenic Bacteria.

Authors:  Adam J Lewis; Amanda C Richards; Matthew A Mulvey
Journal:  Microbiol Spectr       Date:  2016-12

2.  Uropathogenic Escherichia coli-induced fibrosis, leading to lower urinary tract symptoms, is associated with type 2 cytokine signaling.

Authors:  Ashlee Bell-Cohn; Daniel J Mazur; Christel Hall; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Am J Physiol Renal Physiol       Date:  2019-01-09

3.  One size doesn't fit all: unraveling the diversity of factors and interactions that drive E. coli urovirulence.

Authors:  Henry L Schreiber; Caitlin N Spaulding; Karen W Dodson; Jonathan Livny; Scott J Hultgren
Journal:  Ann Transl Med       Date:  2017-01

4.  Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.

Authors:  Henry L Schreiber; Matt S Conover; Wen-Chi Chou; Michael E Hibbing; Abigail L Manson; Karen W Dodson; Thomas J Hannan; Pacita L Roberts; Ann E Stapleton; Thomas M Hooton; Jonathan Livny; Ashlee M Earl; Scott J Hultgren
Journal:  Sci Transl Med       Date:  2017-03-22       Impact factor: 17.956

Review 5.  Urinary Tract Infection: Pathogenesis and Outlook.

Authors:  Lisa K McLellan; David A Hunstad
Journal:  Trends Mol Med       Date:  2016-09-28       Impact factor: 11.951

6.  P2X1, P2X4, and P2X7 Receptor Knock Out Mice Expose Differential Outcome of Sepsis Induced by α-Haemolysin Producing Escherichia coli.

Authors:  Anne-Sofie Greve; Marianne Skals; Steen K Fagerberg; Wulf Tonnus; Svend Ellermann-Eriksen; Richard J Evans; Andreas Linkermann; Helle A Praetorius
Journal:  Front Cell Infect Microbiol       Date:  2017-04-06       Impact factor: 5.293

7.  Context-Dependent Requirements for FimH and Other Canonical Virulence Factors in Gut Colonization by Extraintestinal Pathogenic Escherichia coli.

Authors:  Colin W Russell; Brittany A Fleming; Courtney A Jost; Alexander Tran; Alan T Stenquist; Morgan A Wambaugh; Mary P Bronner; Matthew A Mulvey
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

Review 8.  Prevention and management of urosepsis triggered by ureteroscopy.

Authors:  Kymora B Scotland; Dirk Lange
Journal:  Res Rep Urol       Date:  2018-07-05

9.  Virulence behavior of uropathogenic Escherichia coli strains in the host model Caenorhabditis elegans.

Authors:  Emily Schifano; Massimiliano Marazzato; Maria Grazia Ammendolia; Elena Zanni; Marta Ricci; Antonella Comanducci; Paola Goldoni; Maria Pia Conte; Daniela Uccelletti; Catia Longhi
Journal:  Microbiologyopen       Date:  2018-10-31       Impact factor: 3.139

Review 10.  Recurrent Urinary Tract Infection: A Mystery in Search of Better Model Systems.

Authors:  Benjamin O Murray; Carlos Flores; Corin Williams; Deborah A Flusberg; Elizabeth E Marr; Karolina M Kwiatkowska; Joseph L Charest; Brett C Isenberg; Jennifer L Rohn
Journal:  Front Cell Infect Microbiol       Date:  2021-05-26       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.